MannKind Corp (MNKD): Operating Cash Flow
$18.25M
Year ended 2025-12-31
-$8.05M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $18.25M | -57.1% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $42.51M | +24.7% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $34.09M | n/m | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | -$80.68M | n/m | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | -$61.71M | n/m | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | -$28.13M | n/m | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | -$88.48M | n/m | 2021-02-25, From 2019-01-01 |
| 2018-12-31 | -$37.73M | n/m | 2020-02-25, From 2018-01-01 |
| 2017-12-31 | -$64.78M | n/m | 2019-02-26, From 2017-01-01 |
| 2016-12-31 | -$78.09M | n/m | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | -$57.23M | n/m | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $4.09M | n/m | 2017-03-16, From 2014-01-01 |
| 2013-12-31 | -$128.73M | n/m | 2014-03-03, From 2013-01-01 |
| 2012-12-31 | -$119.86M | n/m | 2014-03-03, From 2012-01-01 |
| 2011-12-31 | -$123.84M | n/m | 2014-03-03, From 2011-01-01 |
| 2010-12-31 | -$148.65M | n/m | 2013-03-18, From 2010-01-01 |
| 2009-12-31 | -$184.08M | n/a | 2012-03-15, From 2009-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| MannKind Corp (MNKD) | 2025-12-31 | $18.25M | -57.1% |
| Arcutis Biotherapeutics, Inc. (ARQT) | 2025-12-31 | -$5.62M | n/m |
| Sinovac Biotech Ltd (SVA) | 2025-12-31 | -$512.18M | n/m |
| CorMedix Inc. (CRMD) | 2025-12-31 | $175.05M | n/m |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | -$42.48M | n/m |
| Evolus, Inc. (EOLS) | 2025-12-31 | -$42.27M | n/m |
| Ironwood Pharmaceuticals Inc (IRWD) | 2025-12-31 | $127.04M | +22.7% |
| Innoviva, Inc. (INVA) | 2025-12-31 | $196.93M | +4.4% |
| Xeris Biopharma Holdings, Inc. (XERS) | 2025-12-31 | $28.63M | n/m |
Compare MNKD, ARQT, SVA, CRMD side by side · Screen every company in Pharmaceutical Preparations ↗